secwatch / observer
8-K filed April 6, 2026, 7:59 PM ET ticker ONCY CIK 0001129928
regulatory confidence high sentiment positive materiality 0.55

Oncolytics schedules Type C FDA meeting for pelareorep single-arm study in anal cancer

ONCOLYTICS BIOTECH INC

item 8.01item 9.01

Machine-readable event card

schema_version
secwatch.filing_event.v1
accession
0001129928-26-000024
form_type
8-K
ticker
ONCY
cik
0001129928
company_name
ONCOLYTICS BIOTECH INC
filed_at
2026-04-06T23:59:59+00:00
discovered_at
2026-05-14T18:02:31.988492+00:00
generated_at
2026-05-15T07:14:04.856288+00:00
sec_items
["8.01", "9.01"]
event_type
regulatory
sentiment
positive
materiality_score
0.55
calibrated_materiality_score
0.55
confidence
high
secwatch_canonical_url
https://secwatch.observer/filing/0001129928-26-000024
json_url
https://secwatch.observer/filing/0001129928-26-000024.json
markdown_url
https://secwatch.observer/filing/0001129928-26-000024.md
text_url
https://secwatch.observer/filing/0001129928-26-000024.txt
edgar_index_url
https://www.sec.gov/Archives/edgar/data/1129928/000112992826000024/0001129928-26-000024-index.htm
edgar_primary_document_url
https://www.sec.gov/Archives/edgar/data/1129928/000112992826000024/oncy-20260406.htm
generated_by_model
deepseek-v4-flash:cloud@v2
review_status
machine_generated
human_reviewed
false
corrected
false
correction_note
null
correction_timestamp
null
superseded_by
null
JSON Markdown Plain text

Comparable filings

TXNM

TXNM subsidiaries: TNMP rate settlement with $20.5M storm rider, PNM resource plan with 1.65 GW renewables

TXNM ENERGY INC June 1, 2026, 5:54 PM ET regulatory Items 7.01, 8.01, 9.01

same SEC item: 8.01, 9.01 same event type: regulatory similar materiality

Filing page SEC filing

RICK

RCI Hospitality regains Nasdaq compliance after filing delayed Q1 10-Q

RCI HOSPITALITY HOLDINGS, INC. June 1, 2026, 3:08 PM ET regulatory Items 8.01, 9.01

same SEC item: 8.01, 9.01 same event type: regulatory similar materiality

Filing page SEC filing

SLXN

Silexion Therapeutics completes 1-for-10 reverse share split; warrants adjusted

Silexion Therapeutics Corp May 29, 2026, 7:00 AM ET regulatory Items 3.03, 5.03, 8.01, 9.01

same SEC item: 8.01, 9.01 same event type: regulatory similar materiality

Filing page SEC filing

JAGX

Jaguar Health regains Nasdaq Bid Price compliance; monitoring until May 2027

Jaguar Health, Inc. May 27, 2026, 9:10 AM ET regulatory Items 7.01, 8.01, 9.01

same SEC item: 8.01, 9.01 same event type: regulatory similar materiality

Filing page SEC filing

MBOT

Microbot Medical receives Israeli regulatory approval for LIBERTY System, first outside U.S.

Microbot Medical Inc. May 26, 2026, 8:30 AM ET regulatory Items 7.01, 8.01, 9.01

same SEC item: 8.01, 9.01 same event type: regulatory similar materiality

Filing page SEC filing

AVXL

Anavex receives Nasdaq delinquency notice for late 10-Q filing; deadline July 20, 2026

ANAVEX LIFE SCIENCES CORP. May 22, 2026, 8:15 AM ET regulatory Items 3.01, 8.01, 9.01

same SEC item: 8.01, 9.01 same event type: regulatory similar materiality

Filing page SEC filing

ADGM

Adagio submits PMA to FDA for vCLAS VT ablation system; trial shows 97.4% acute success

Adagio Medical Holdings, Inc. May 21, 2026, 4:31 PM ET regulatory Items 8.01, 9.01

same SEC item: 8.01, 9.01 same event type: regulatory similar materiality

Filing page SEC filing

CGTX

Cognition Therapeutics completes productive FDA meeting for zervimesine in DLB psychosis

COGNITION THERAPEUTICS INC May 21, 2026, 7:34 AM ET regulatory Items 8.01, 9.01

same SEC item: 8.01, 9.01 same event type: regulatory similar materiality

Filing page SEC filing

Source: SEC EDGAR
accession 0001129928-26-000024
view filing index on sec.gov
view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.